![]() |
Trials |
A randomized phase II trial of imatinib alternating with regorafenib compared to imatinib alone for the first line treatment of advanced gastrointestinal stromal tumor (GIST)Cancer type: Gastric cancer Phase: II Principal Investigator: Joensuu Heikki Country: FI Keywords: Finland, Helsinki, Status: Open for inclusion |